Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate. A new analysis in Diabetes/Metabolism Research and Reviews suggests that weight-loss surgery—also called metabolic-bariatric surgery—may lower the risk of developing pancreatic cancer in people with obesity, especially in those who also have type 2 diabetes. In the systematic review and meta-analysis,...
Tag: <span>Weight loss</span>
Post
Ghost Fat: The Unseen Consequences of Weight Loss
612 Many people who lose weight, whether through diet and lifestyle changes, medication, or bariatric surgery, recognize their body has changed. While they also experience improvements in quality of life and psychosocial areas, that’s not true for everyone. Some patients don’t “see” they’ve lost weight — a phenomenon referred to as “phantom fat,” “ghost fat,” or “vestigial body image.”...
Post
A New Study Finds Weight Loss Drugs Like Ozempic Could Cause Bone Loss. Doctors Share How To Protect Yourself
These “are the biggest concerns” for doctors. By Korin MillerPublished: Sep 19, 2024 3:42 PM EDT Getty ImagesResearch has shown there are plenty of perks of using a medication like Ozempic for weight loss. But, given that this is a drug, there are some potential downsides to consider, too. New research published in JAMA Network...
Post
Research assesses impact of weight loss and blood sugar control in Type 2 Diabetes
News Release 17-Sep-2024 Study finds that type 2 diabetes patients treated with GLP-1RAs who lowered their BMI also reduced their cardiovascular risk Peer-Reviewed PublicationCleveland Clinic A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2...
Post
Survey shows 25% of adults consider weight loss drug use without prescription
September 17, 2024 by Ohio State University Medical Center Credit: Markus Winkler from PexelsInjectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is that some people are skipping the doctor’s office and reaching out to potentially unreliable...
Post
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
By Meg Tirrell, CNNPublished 6:30 AM EDT, Tue September 17, 2024 The new crop of GLP-1 weight loss drugs all come in the form of injections. New pill versions are in trials now. Illustration by Leah Abucayan/CNNJared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually...
Post
Tirzepatide associated with greater weight loss in women than men
September 11, 2024 by Diabetologia Credit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of the...
Post
Weight loss drug liraglutide is safe and effective in children under 12, study finds
September 10, 2024 by Diabetologia Credit: Lukas from PexelsThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of...
Post
Is weight loss as simple as calories in, calories out? In the end, it may be gut microbes that make calories count
September 10, 2024 by Christopher Damman, The Conversation Credit: Pixabay/CC0 Public DomainIs the adage “calories in, calories out” true? The short answer is yes, but the full story is more nuanced. From the moment food touches your tongue to the time it leaves your body, your digestive system and gut microbiome work to extract its...
Post
‘Remarkable’ Weight Loss Seen With Novel Oral Combination That Is Safe and Tolerable in Phase 1 Study
Medscape Medical News > Conference News > EASD 2024 Becky McCall September 12, 2024 MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants with overweight or obesity according to phase 1, first-in-human study data presented at the European Association for the Study of Diabetes...